Valink Therapeutics
Drug DiscoveryWebsite
Valink Therapeutics valuation and funding history | Last updated: October 20, 2025 | 1 funding rounds
Current Valuation
N/A
As of October 20, 2025
Total Funding Raised
$20.5M
Across 1 round
Last Round
Later Stage VC
$11.8M
Last Funding
Oct 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| November 3, 2023 | Seed Round | $7.6M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Valink Therapeutics is currently valued at N/A as of October 20, 2025. The company has raised a total of $20.5M in funding across 1 funding round.
What is Valink Therapeutics Worth in 2026?
Valink Therapeutics is a leading private company in the Drug Discovery sector. Track Valink Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Valink Therapeutics Valuation is Determined
Private company valuations like Valink Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.